TSRI professor receives $3.75M "mega-grants" from Russian government

NewsGuard 100/100 Score

Valery Fokin, professor in the Department of Chemistry at The Scripps Research Institute (TSRI), has been awarded a prestigious grant from the Russian government for $3.75 million over three years, with the possibility of a two-year renewal. The grant will fund the establishment of a laboratory at the Moscow Institute of Physics and Technology (MIPT).

This highly competitive program-called "mega-grants" in Russia-is aimed at recruiting the expertise of leading scientists in a variety of fields, ranging from history and archeology to industrial biotechnology, to reinvigorate Russian science. Among the 42 winners are researchers from countries including USA, Russia, Germany, Japan, France, Spain, Israel, Australia and Israel.

"Doing research on two continents is a challenging but rewarding endeavor," says Fokin. "With the support of this grant and administrations of both institutes, I am hoping that our work will benefit from synergies and will result in mutually beneficial collaborations between Scripps and Russian scientists and pharmaceutical and biotechnology companies, leading to new technologies and products in both nations."

Fokin will assemble a team of graduate students, postdoctoral fellows and staff scientists to work at the newly established laboratory on the development of new chemical transformations and their use in studies of biomarkers for the diagnosis and treatment of inflammation, cancer and immune diseases.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings